ANTIBIOTIKLARGA SEZUVCHANLIK VA CHIDAMLILIK AHAMIYATI
PDF
DOI

Keywords

antibiotiklar, sezuvchanlik, chidamlilik, antimikrob rezistentlik (AMR), bakterial infeksiyalar, antibiotik sezuvchanlik testi (AST), terapevtik strategiya, jamoat salomatligi, minimal inhibitiv konsentratsiya (MIC).

How to Cite

ANTIBIOTIKLARGA SEZUVCHANLIK VA CHIDAMLILIK AHAMIYATI. (2026). Journal of Universal Science Research, 4(3), 211-219. http://universalpublishings.com/index.php/jusr/article/view/17758

Abstract

Antibiotiklar zamonaviy tibbiyotda bakterial infeksiyalarni davolashda terapevtik ahamiyati beqiyos bo'lgan farmakologik vositalar hisoblanadi. Biroq, ularning klinik samaradorligi mikroorganizmlarning antibiotiklarga sezuvchanligi va chidamliligi bilan bevosita bog'liqdir. Ushbu maqola antibiotiklarga sezuvchanlikni aniqlashning klinik va epidemiologik ahamiyatini, shuningdek, antimikrob chidamlilik mexanizmlarini, tarqalish yo'llarini va global sog'liqni saqlashga tug'dirayotgan tahdidini mikrobiologik nuqtai nazardan tahlil qiladi. 

PDF
DOI

References

1. Singh, T.S.G., & Singh, A.K. (Eds.). Antimicrobial Resistance: A Global Threat. Singapore: Springer, 2020.

2. Singh, V.K. (Ed.). Mechanisms of Antimicrobial Resistance. Academic Press, 2022.

3. Murray, C.J.L., et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655, 2022.

4. Tacconelli, E., et al. Discovery, research, and development of new antibiotics: the WHO priority list. The Lancet Infectious Diseases, 21(12), e395–e406, 2021.

5. Van Belkum, A., et al. Rapid antimicrobial susceptibility testing: current and potential future approaches. Clinical Microbiology Reviews, 34(2), e00082-20, 2021.

6. Blair, J.M.A., et al. Molecular mechanisms of antibiotic resistance. Nature Reviews Microbiology, 18(1), 42–51, 2020.

7. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, v.14.0. European Committee on Antimicrobial Susceptibility Testing, 2024.

8. WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Geneva: World Health Organization, 2022.

9. Liu, Y., et al. Emerging mechanisms of antibiotic resistance in Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 76(1), 1–14, 2021.

10. Theuretzbacher, U., et al. Clinical pipeline of new antibiotics and non-traditional antibacterial therapeutics: 2021 update. Clinical Infectious Diseases, 73(2), e105–e121, 2021.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.